Safety and Pharmacokinetic (PK) Study to Assess Bronchopulmonary Disposition of IV Eravacycline (TP-434) in Healthy Men and Women
Clinical trial NCT01989949 · COMPLETED
Trial details
- NCT number
- NCT01989949
- Sponsor
- Tetraphase Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-01-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.